Move to Levit Green: From Lab to Market: Biotech

In Houston, PranaX, a pioneering company in regenerative science, has leased space in the new Levit Green life sciences district on Holcombe Boulevard, demonstrating a leap of locally developed technology moving toward the scientific manufacturing marketplace.

Houston-based Hines, the global real estate investment manager, in partnership with 2ML Real Estate Interests and Harrison Street, reported the PranaX lease at Levit Green, a 53-acre multi-use life sciences-centric district adjacent to the Texas Medical Center near Highway 288.

PranaX, a pioneering company in regenerative science, leased a 7,400-SF, turn-key lab space on the second floor of Levit Green’s Phase I building. PranaX is moving into its new space immediately, demonstrating move-in-ready nature of the space.

“PranaX’s work start work represents exactly the kind of innovation and collaboration that Levit Green was designed to foster,” said John Mooz, senior managing director at Hines. “We recognized the need in the market to provide immediate, state-of-the-art research facilities and look forward to supporting PranaX in their mission to manufacture regenerative therapies.”

PranaX is an emerging biotechnology company dedicated to harnessing exosomes to rejuvenate aging, inflamed, and damaged tissues and organs. The company’s goal is to unlock the regenerative properties of exosomes to enhance quality of life, contributing to healthier, more fulfilling lives.

“This is an amazing opportunity to retain technology developed locally and expand upon it within the Houston biotech ecosystem, said Steven J. Greco, PhD, Founder and Chief Operating Officer of PranaX.

PranaX has entered into a technology licensing agreement with The University of Texas MD Anderson Cancer Center and aims to utilize this technology to commercialize exosomes as therapeutics, natural supplements and wellness products that can promote healthy aging. The company’s research and development and manufacturing operations will be headquartered in Houston, within Levit Green.

PranaX, a pioneering company in regenerative science, leased a 7,400-SF, turn-key lab space on the second floor of Levit Green’s Phase I building.near the Texas Medical Center in Houston. Photo courtesy Hines

ISO-7 Clean Room Will Meet FDA Standards for Manufacturing Therapies

In collaboration with Hines, PranaX is working to convert one of the lab’s support rooms into an ISO-7 clean room that meets FDA standards. This clean room will be instrumental in manufacturing approved therapies for patients at their offsite clinic, further enhancing the suite’s capabilities to support cutting-edge research and development. Additionally, PranaX will utilize the suite to offer exosome banking services, an innovative approach to support wound healing and initiate cell growth and development. This service aligns with the growing interest in personalized medicine and the potential for clinical breakthroughs in the treatment of serious medical conditions.

Dr. Stan Watowich, the founder and CEO of nearby Ridgeline Therapeutics, commented on Levit Green’s transformative potential at a recent Greater Houston Partnership event, saying, “I view Levit Green as Houston’s newest cathedral for biomedical innovation, a destination where visionary biotech companies will receive inspiration, collaboration and support as they continue their quest to bring life-changing healthcare technologies to patients.”

Completed in 2023, Levit Green’s first phase is a lab, biomanufacturing facility designed with flexibility in mind to meet the evolving needs of the life sciences industry. The 290,000-SF, five-story building is part of the broader nine-building Levit Green master plan, which will offer a curated mix of research and production facilities, office, retail, residential, and outdoor amenities. The building has two turnkey laboratory suites, each approximately 11,000 SF, available for immediate occupancy and leasing.

Hines, founded by Mr. Gerald D. Hines in 1957, operates in 30 countries.